Gabriella Scarlatti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape.
Journal: Open forum infectious diseases
Published: July 08, 2025
In danger: HIV vaccine research and development in Europe.
Journal: PLOS global public health
Published: April 08, 2025
Monitoring broadly neutralising HIV antibody concentrations using microsampling on dried blood spots in infants.
Journal: The Journal of infection
Published: April 07, 2025
Simian Immunodeficiency Virus-Based Virus-like Particles Are an Efficient Tool to Induce Persistent Anti-SARS-CoV-2 Spike Neutralizing Antibodies and Specific T Cells in Mice.
Journal: Vaccines
Published: December 30, 2024
Safety and pharmacokinetics of subcutaneous administration of broadly neutralizing anti-HIV-1 monoclonal antibodies (bNAbs), given to HIV-1 exposed, uninfected neonates and infants: study protocol for a phase I trial.
Journal: BMC infectious diseases
Published: June 24, 2024
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth.
Journal: EBioMedicine
Published: April 26, 2024
The longitudinal characterization of immune responses in COVID-19 patients reveals novel prognostic signatures for disease severity, patients' survival and long COVID.
Journal: Frontiers in immunology
Published: February 02, 2024
Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit all.
Journal: Immunity, inflammation and disease
Published: December 21, 2023
Ex vivo challenge models for infectious diseases.
Journal: Critical reviews in microbiology
Published: November 01, 2023
Last Updated: 09/26/2026